BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25799176)

  • 1. The Effect of Androgen Deprivation Therapy Before Salvage Whole-gland Cryoablation After Primary Radiation Failure in Prostate Cancer Treatment.
    Li R; Ruckle HC; Schlaifer AE; El-Shafei A; Yu C; Jones JS
    Urology; 2015 May; 85(5):1137-1142. PubMed ID: 25799176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Avoidance of androgen deprivation therapy in radiorecurrent prostate cancer as a clinically meaningful endpoint for salvage cryoablation.
    Ginsburg KB; Elshafei A; Yu C; Jones JS; Cher ML
    Prostate; 2017 Oct; 77(14):1446-1450. PubMed ID: 28856702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upfront androgen deprivation therapy with salvage radiation may improve biochemical outcomes in prostate cancer patients with post-prostatectomy rising PSA.
    Jang JW; Hwang WT; Guzzo TJ; Wein AJ; Haas NB; Both S; Vapiwala N
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1493-9. PubMed ID: 22401922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage Prostate Cryoablation for the Management of Local Recurrence After Primary Cryotherapy: A Retrospective Analysis of Functional and Intermediate-Term Oncological Outcomes Associated With a Second Therapeutic Freeze.
    Aminsharifi A; Jibara G; Tsivian E; Tsivian M; Elshafei A; Polascik TJ
    Clin Genitourin Cancer; 2019 Aug; 17(4):e831-e836. PubMed ID: 31213413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-Year Biochemical Progression-Free Survival Following Salvage Whole-Gland Prostate Cryoablation: Defining Success with Nadir Prostate-Specific Antigen.
    Kovac E; ElShafei A; Tay KJ; Mendez M; Polascik TJ; Jones JS
    J Endourol; 2016 Jun; 30(6):624-31. PubMed ID: 26915721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low rates of androgen deprivation therapy use with salvage radiation therapy in patients with prostate cancer after radical prostatectomy.
    Yang DD; Muralidhar V; Mahal BA; Nezolosky MD; Labe SA; Vastola ME; Boldbaatar N; King MT; Martin NE; Orio PF; Choueiri TK; Trinh QD; Den RB; Spratt DE; Hoffman KE; Feng FY; Nguyen PL
    Urol Oncol; 2017 Sep; 35(9):542.e25-542.e32. PubMed ID: 28533151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage focal cryosurgery may delay use of androgen deprivation therapy in cryotherapy and radiation recurrent prostate cancer patients.
    Kongnyuy M; Berg CJ; Kosinski KE; Habibian DJ; Schiff JT; Corcoran AT; Katz AE
    Int J Hyperthermia; 2017 Nov; 33(7):810-813. PubMed ID: 28540788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvage Cryoablation for Recurrent Prostate Cancer Following Primary External Beam Radiotherapy or Primary Cryotherapy: A Propensity Score Matched Analysis of Mid-term Oncologic and Functional Outcomes.
    Campbell SP; Deivasigamani S; Arcot R; Adams ES; Orabi H; Elshafei A; Tan WP; Davis L; Wu Y; Chang A; Jones JS; Polascik TJ
    Clin Genitourin Cancer; 2023 Oct; 21(5):555-562. PubMed ID: 37438234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment failure and clinical progression after salvage therapy in men with biochemical recurrence after radical prostatectomy: radiotherapy vs androgen deprivation.
    Song C; Kim YS; Hong JH; Kim CS; Ahn H
    BJU Int; 2010 Jul; 106(2):188-93. PubMed ID: 20002666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-institutional Evaluation of Elective Nodal Irradiation and/or Androgen Deprivation Therapy with Postprostatectomy Salvage Radiotherapy for Prostate Cancer.
    Ramey SJ; Agrawal S; Abramowitz MC; Moghanaki D; Pisansky TM; Efstathiou JA; Michalski JM; Spratt DE; Hearn JWD; Koontz BF; Liauw SL; Pollack A; Anscher MS; Den RB; Stephans KL; Zietman AL; Lee WR; Stephenson AJ; Tendulkar RD
    Eur Urol; 2018 Jul; 74(1):99-106. PubMed ID: 29128208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Operative and Midterm Oncological Outcome of Focal Salvage Cryotherapy for Localized Prostate Cancer.
    Vestris PG; Giwerc A; Hennequin C; Goujon A; Meria P; Verine J; Desgrandchamps F; de Kerviler E; Mongiat-Artus P; Masson-Lecomte A
    Urol Int; 2022; 106(9):897-902. PubMed ID: 34781287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy.
    Jackson WC; Schipper MJ; Johnson SB; Foster C; Li D; Sandler HM; Palapattu GS; Hamstra DA; Feng FY
    Eur Urol; 2016 Jan; 69(1):50-7. PubMed ID: 26004800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does neoadjuvant androgen deprivation therapy before primary whole gland cryoablation of the prostate affect the outcome?
    Grossgold E; Given R; Ruckle H; Jones JS
    Urology; 2014 Feb; 83(2):379-83. PubMed ID: 24315304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant androgen-deprivation therapy following prostate total cryoablation in high-risk localized prostate cancer patients - Open-labeled randomized clinical trial.
    Chen CH; Pu YS
    Cryobiology; 2018 Jun; 82():88-92. PubMed ID: 29626465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propensity Score-Matched Comparison of Partial to Whole-Gland Cryotherapy for Intermediate-Risk Prostate Cancer: An Analysis of the Cryo On-Line Data Registry Data.
    Tay KJ; Polascik TJ; Elshafei A; Tsivian E; Jones JS
    J Endourol; 2017 Jun; 31(6):564-571. PubMed ID: 28385075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The need for androgen deprivation therapy in patients with intermediate-risk prostate cancer treated with dose-escalated external beam radiation therapy.
    Dong Y; Ruth KJ; Churilla TM; Viterbo R; Sobczak ML; Smaldone MC; Chen DY; Uzzo RG; Hallman MH; Horwitz EM
    Can J Urol; 2017 Feb; 24(1):8656-8662. PubMed ID: 28263132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing D'Amico risk groups in radical prostatectomy through the addition of magnetic resonance imaging data.
    Algarra R; Zudaire B; Tienza A; Velis JM; Rincón A; Pascual I; Zudaire J
    Actas Urol Esp; 2014 Nov; 38(9):594-9. PubMed ID: 24791621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage radiation therapy following radical prostatectomy. A national Danish study.
    Ervandian M; Høyer M; Petersen SE; Sengeløv L; Hansen S; Holmberg M; Sveistrup J; Meidahl Petersen P; Borre M
    Acta Oncol; 2016 May; 55(5):598-603. PubMed ID: 26399602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen deprivation therapy during and after post-prostatectomy radiotherapy in patients with prostate cancer: a case control study.
    Kim M; Song C; Jeong IG; Choi SK; Park M; Shim M; Kim YS; You D; Hong JH; Kim CS; Ahn H
    BMC Cancer; 2018 Mar; 18(1):271. PubMed ID: 29523103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continued benefit to androgen deprivation therapy for prostate cancer patients treated with dose-escalated radiation therapy across multiple definitions of high-risk disease.
    Stenmark MH; Blas K; Halverson S; Sandler HM; Feng FY; Hamstra DA
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e335-44. PubMed ID: 21645976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.